Few observations:-
-
Phoenix face tough time with brand recall in B2C segment – During my visit to a Maruti Suzuki dealer, I observed a big poster on halogen lamps promoted by Philips. While Phoenix supplies halogen bulbs to most Maruti vehicles it is not a familiar name among retail consumers. Philips, on the other hand is in fact a household name and is trying to capitalise the same by offering win-win situation for both Maruti (peddling the Philips product at an extra cost to the consumer) and itself (in terms of displacing an established OEM supplier like PLL).
-
Working Capital Days (Cash conversion cycle) looks to be an issue. For Standalone basis, it is coming at ~120 days, for consolidated its coming at ~95 days. Is it due to sales mix of aftermarket/OEM??
-
Bleeding European subsidiaries are a concern and bring down EBITDA (at standalone basis) from +20% to ~12.5% (at consolidated basis). Infact in FY14 CFO decreased from INR 770 Mn to -INR 100 Mn. Even with management guidance of ~14.5% EBITDA, may be Euro. subsidaries would not be so profitable in near term
-
Looks more like wait and watch game where how new promoters can turn it around
-
Few other queries, would help if anyone has answer on it:-
a. production level/capacities for European subsidaries? what are the highest levels they can operate?
b. Working Capital management?
c. Capex cost of setting up manufcaturing unit, lets say 10 bulbs/yr?
d. reason for spike in sales in FY14 even at Standalone level
Phoenix Lamps – General Research.xlsx (62.2 KB)
Disc. Not invested. Have also posted numbers excel herewithin…
Subscribe To Our Free Newsletter |